Newsletter | November 30, 2023

Best of November: Top 5 Insights In Drug Formulation & Delivery

Drug Delivery Leader



#1 FDA Releases Q&A Guidance On Human Factors Engineering For Combination Products

To support the co-packaged design process, the FDA has issued a new guidance document titled Application of Human Factors Engineering Principles for Combination Products: Questions and Answers. Tim Sandle reviews pertinent points from the guidance.

#2 Evolution Of A Novel Polymer To Overcome Limitations In Sustained Drug Delivery

Degradable polymers evolved from aliphatic polyesters to nitrogen-bearing biomaterials such as polyurethanes, polyester amides, and polyureas. Explore a brief history of the development of PEA polymers.

#3 Emerging Trends In Infusion/IV Therapy

The infusion therapy market in the U.S. is growing rapidly, driven by an aging population and the increasing prevalence of chronic diseases. This article shares new market research, with a look at macro trends as well as trends in infusion pumps, IV sets, needleless connectors, stopcocks, IV filters, and blood transfusion sets.

#4 Prefilled Syringes Market Trends: Improving Patient Experience

Learn how sterile injectable devices are providing safer and more convenient self-injection delivery, leading to positive patient experiences, better therapy adherence, and improved outcomes.

#5 5 Hot-Button Issues In Parenteral Packaging

Innovation and scientific understanding remain at the heart of the pharmaceutical parenteral packaging industry. At the recent PDA Parenteral Packaging Conference held in Venice, Italy, 5 specific issues were reinforced throughout the two-day event.